Podiatrists in District Of Columbia - Medicare Status, Address, Contact
91 Podiatrists found. Showing 81 - 91
 National Capital Foot & Ankle Center Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 5100 Wisconsin Ave Nw Ste 522, Washington, DC 20016 Phone: 202-966-0900 Fax: 202-966-0836 |
 Dr. Maxwell John Levene, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 700 2nd St Ne, Washington, DC 20002 Phone: 202-346-3000 |
Foot And Ankle Specialists Of The Mid-atlantic, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1775 K St Nw Ste 580, Washington, DC 20006 Phone: 202-331-9727 |
Ijeoma Nwuju, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1160 Varnum St Ne Ste 200, Washington, DC 20017 Phone: 202-635-8306 |
Foxhall Podiatry Associates, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 3301 New Mexico Ave Nw, Suite 228, Washington, DC 20016 Phone: 202-966-4811 Fax: 202-686-0932 |
 Maxine Eunita Miller, DPM Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1560 27th St Se, Suite 102, Washington, DC 20020 Phone: 202-584-4114 |
Dr. Jayson Nicholas Atves, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw Bldg 1, Washington, DC 20007 Phone: 202-444-9686 |
Peters Podiatry Group Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1008 Hamlin St Ne, Washington, DC 20017 Phone: 202-270-0388 |
Dr. Kevin C. Bradshaw, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 519 Peabody St Ne, Washington, DC 20011 Phone: 202-285-1465 Fax: 202-635-2305 |
Dr. Stephen Jeremy Kominsky, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 4910 Massachusetts Ave Nw, Suite 315, Washington, DC 20016 Phone: 202-362-2883 Fax: 202-362-3330 |
Providence Foot Health Center Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 1160 Varnum St Ne Ste 12, Washington, DC 20017 Phone: 202-269-4062 |
News Archive
High cardiorespiratory fitness levels reduce risk of arrhythmia recurrence in obese atrial fibrillation patients
Obese atrial fibrillation patients have a lower chance of arrhythmia recurrence if they have high levels of cardiorespiratory fitness, and risk continues to decline as exercise capacity increases as part of treatment, according to a study published today in the Journal of the American College of Cardiology.
Plastic corneal prosthesis for patients unable to tolerate donor corneas
For many patients who become blind after an accident or illness, a corneal transplantation could restore the ability to see. Each year, 40,000 people in Europe - in Germany, about 7,000 - await the opportunity to be able to see again, thanks to cornea donors. But donor corneas are not common. Dr. Joachim Storsberg of the Fraunhofer Institute for Applied Polymer Research IAP in Potsdam-Golm developed material and production process for a corneal prosthesis made of plastic.
More than 20 million COVID-19 tests analyzed at Glasgow Lighthouse Lab
The Glasgow Lighthouse Lab has now analyzed more than 20 million COVID-19 tests, as Health and Social Care Secretary, Sajid Javid visited the lab today [Wednesday 10 November] to thank staff for their tireless work.
Study discourages use of non-standard therapies for infantile spasms
Children with infantile spasms, a rare form of epileptic seizures, should be treated with one of three recommended therapies and the use of non-standard therapies should be strongly discouraged, according to a study of their effectiveness by a Weill Cornell Medicine and NewYork-Presbyterian investigator and collaborating colleagues in the Pediatric Epilepsy Research Consortium. Early treatment with an effective therapy is important for improving neurodevelopmental outcomes and, for some children, can result in permanent remission of epilepsy.
Actavis' subsidiary files lawsuit against FDA over Celebrex decision
Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.
› Verified 5 days ago